Table 2.
Patient Groups | Number of Patients, n (%) | |||||
---|---|---|---|---|---|---|
S. epidermidis (MSSE) | S. epidermidis (MRSE) | S. aureus (MSSA) | S. haemolyticus (MSSH) | S. aureus (MRSA) | Total per Group | |
Study group (SG) |
8 (34.8%) |
6 (26.1%) |
8 (34.8%) |
0 (0.0%) |
1 (4.3%) |
23 (100.0%) |
Comparator group (CG) | 4 (18.2%) |
3 (13.6%) |
13 (59.1%) |
2 (9.1%) |
0 (0.0%) |
22 (100.0%) |
Total | 12 (26.7%) |
9 (20.0%) |
21 (46.7%) |
2 (4.4%) |
1 (2.2%) |
45 (100.0%) |